Donald Trump nominates Pam Bondi for US attorney-general after Matt Gaetz drops out - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
美国

Donald Trump nominates Pam Bondi for US attorney-general after Matt Gaetz drops out

Announcement comes just hours after controversial initial nominee withdrew from consideration for the role

US president-elect Donald Trump has nominated Pam Bondi for attorney-general just hours after Matt Gaetz, his initial pick, withdrew from consideration for the role.

The unexpected move injected fresh drama into Trump’s selection of cabinet nominees, as he seeks to swiftly secure a head for the Department of Justice, one of the most important posts in his incoming administration.

A former Florida attorney-general, Bondi is seen as a less controversial pick than Gaetz, the former firebrand congressman. But she is a Trump ally who defended the president-elect’s efforts to question the result of the 2020 election.

“For too long, the partisan Department of Justice has been weaponized against me and other Republicans — Not any more,” Trump wrote on his platform Truth Social on Thursday. “Pam will refocus the DOJ to its intended purpose of fighting Crime, and Making America Safe Again.”

He added that Bondi, a former Florida attorney-general, was “smart and tough, and is an AMERICA FIRST Fighter, who will do a terrific job as Attorney General!”

Bondi is a partner at Ballard Partners, an influential lobbying firm in Washington, where she chairs its corporate regulatory compliance practice. She could not immediately be reached for comment.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

谷歌为Anthropic打造的2000亿美元华尔街融资机器

私募信贷、芯片租赁和数据中心担保,支撑起AI支出的全新庞大模式。

“日元干预”等于“美国自保”

美国联手日本支撑日元,不只是出于盟友情谊,更是为了避免日本加息或美国国债遭抛售、导致美债收益率进一步走高。

“诅咒之岛”:科技游民与诈骗犯藏身的千亿美元奢华开发项目

警方的突击搜查再次打击了马来西亚陷入困境的中资“森林城市”项目的声誉。

问题不在因凡蒂诺

马杜罗:应该将国际足联的监管职能与商业活动分开,其治理应真正做到包容并具有代表性,监督必须真正独立。

俄罗斯扩大“影子”液化天然气船队,应对欧盟禁令

随着明年制裁进一步收紧,越来越多的“影子”船舶将帮助俄罗斯继续出口液化天然气。

阿斯利康与百时美施贵宝:大药企有时也不够大

当资产负债表规模扩大、能够押注潜在重磅药物时,规模才会带来优势。
设置字号×
最小
较小
默认
较大
最大
分享×